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Abstract
Introduction
Evaluations of weight management programs in realworld settings are lacking. The RE-AIM model (reach,
effectiveness, adoption, implementation, maintenance)
was developed to address this deficiency. Our primary
objective was to evaluate a 12-week insurance-sponsored
weight management intervention by using the RE-AIM
model, including short-term and long-term individual
outcomes and setting-level implementation factors. Our
secondary objective was to critique the RE-AIM model and
its revised calculation methods.
Methods
We created operational definitions for components of the
5 RE-AIM indices and used standardized effect size values
from various statistical procedures to measure multiple
components or outcomes within each index. We used χ2
analysis to compare categorical variables and repeatedmeasures analysis of variance to assess the magnitude of
outcome changes over time.
Results
On the basis of data for 1,952 participants and surveys

completed by administrators at 23 sites, RE-AIM indices
ranging from 0 to 100 revealed low program reach and
adoption (5.4 and 8.8, respectively), moderate effectiveness (43.8), high implementation (91.4), low to moderate
individual maintenance (21.2), and moderate to high site
maintenance (77.8). Median (interquartile range) weight
loss was 13 lb (6.5-21.4 lb) among participants who completed phase I (12 weeks; 76.5%) and 15 lb (6.1-30.3 lb)
among those who completed phase II (1 year; 45.7%).
Conclusions
This program had a significant, positive effect on participants and has been sustainable but needs to be expanded
for more public health benefit. The RE-AIM model provided a useful framework to determine program strengths
and weaknesses and to present them to the insurance
agency and public health decision makers.

Introduction
Regardless of the success of diet and physical activity
programs in controlled research settings (1-6), if largescale programs are not effective or easily implemented
in real-world settings they fall short of their intended
purpose. In the Strategic Plan for NIH Obesity Research,
the National Institutes of Health Obesity Research Task
Force (7) outlined a national strategy for obesity research
emphasizing the use of translational research. However,
evaluation of the translation of effective programs to realworld settings is lacking (8).
The RE-AIM model (9) was developed as a tool to
evaluate health promotion programs along 5 dimensions: reach, effectiveness, adoption, implementation, and
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maintenance. Reach refers to the percentage of potential
participants who enroll and their representativeness of
the target population; effectiveness, to the changes in
participant outcomes during the program; adoption, to the
number and representativeness of sites willing to conduct
the program; implementation, to site adherence to program protocols; and maintenance, to individual outcomes
after final intervention contact and program continuation
at sites over the long term (8-10).
The RE-AIM model has been used to evaluate a limited
number of programs, including 14 WISEWOMAN cardiovascular screening interventions in North Carolina (11),
a church-based physical activity intervention in South
Carolina (12), and 2 diabetes self-management interventions (13). To our knowledge, no evaluation of a large-scale
weight management program using RE-AIM methods
has been published, but studies have shown the model is
applicable to a variety of health behaviors and programs.
Additionally, researchers have recommended revising REAIM index calculation methods to reduce the likelihood of
difficult-to-interpret negative values (13).
Our primary objective was to use RE-AIM to evaluate
a multisite, insurance-sponsored weight management
program that produced positive short-term physical and
psychosocial changes in participants in a university laboratory setting. Our secondary objective was to critique
the RE-AIM model’s usefulness as an evaluation tool for
health promotion programs. We analyzed 3- and 12-month
participant outcomes and site-level program implementation information.

Methods
This study evaluated a weight management program
that has been offered since 2004 by a large public employees’ insurance agency in West Virginia as a benefit to its
members. Obese insured members (body mass index [BMI]
≥30 kg/m2) are eligible for the program, as are overweight
members (BMI 25.0-29.9 kg/m2) who also report being
treated for hypertension, diabetes, heart disease, metabolic syndrome, or sleep apnea. Participants enroll in the
program by calling the insurance agency to be screened
for height, weight, and health information and must have
written approval from their primary care physician.
The insurance agency also screens site providers to

ensure the site has adequate safety devices, exercise
equipment, and staffing to accommodate high-risk participants. At the time of this study, the insurance agency
had approved 31 fitness facilities (“sites”) to accept participants: 2 housed in university cardiac rehabilitation/
exercise physiology laboratories, 2 in physical therapy
facilities, 5 in hospitals, and 22 private wellness/fitness
centers. Searches of available print (14) and online (www.
wvha.com, www.yellowpages.com) resources yielded 352
of these types of facilities in West Virginia. Each approved
site is required to designate an administrator to act as liaison with the insurance agency, handle participant contact,
coordinate site services, and enter participant data into a
database.
The weight management program evaluated in this
study is a 1-year benefit, during which weight loss is promoted by using a combination of behavior therapy (eg, food
logs), individualized site-based exercise programming, and
individualized diet therapy. Case management nurses
track participant progress on the basis of monthly entry of
the following body measurements by the sites into a Webbased database: weight and BMI, systolic and diastolic
blood pressure, body fat percentage, waist circumference,
and number of site visits. Each site determines its measurement protocols on the basis of available instruments
and staff training. Sites are compensated via monthly
member copayments and insurance agency payments for
the provision of on-site services in 2 phases.

Phase I (months 1-3)
Services provided during phase I include 1) access to
the exercise site, 2) a 60-minute fitness evaluation and
exercise program designed by an exercise physiologist, 3)
a 60-minute evaluation and nutrition program designed
by a registered dietitian, 4) monthly 30-minute exercise
sessions with a personal trainer, and 5) 60-minute follow-up reassessments by the exercise physiologist and
registered dietitian at the end of month 3. Participants
may be removed from the program if they fail to exercise
at the site at least twice per week; turn in food logs periodically; attend appointments with the exercise physiologist, registered dietitian, or personal trainer; or have body
measurements taken by site staff monthly. Phase I is
considered the “intervention” period for this evaluation.
If participants meet the behavioral requirements and lose
12 lb (or show substantial improvements in other physical
measures) they may continue to phase II.
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to complete an online survey.
The survey assessed 1) site
Definition
Phase II spans the remainder RE-AIM Component
staffing, equipment, and facilof the first year (9 months). This Individual participation The percentage of eligible members of the
ities; 2) program implementainsurance agency who participated in the
phase is considered the postint- rate (IPR)
tion methods; and 3) barriweight management program
ervention period for the current
ers to program implementaevaluation because it is more Demographic repretion. Section 2 of the survey
How well participants represented the
population eligible for the program
like a private gym membership sentativeness (DR)
was relevant to this study;
than a weight-loss intervention; Individual completion
it included items that ascerThe percentage of participants who comit provides access to the facility rate (ICR)
tained the procedures (openpleted each of the phases of the weight
and 1 personal training session
ended) or frequency (categorimanagement program
per month. Participants are
cal) of conducting 14 program
Outcomes (O)
Weight change experienced by completers
expected to continue exercising
components during phase I as
of each phase of the weight management
at the facility twice per week
recommended or required by
program
and have physical measurethe insurance agency: meaDifferential impact (DI) A measure of differential changes in
ments and visit data submitted
suring weight, waist circumweight experienced among phase I and II
monthly by the sites to mainference, body fat percentage,
completers by sex and age
tain the benefit.
and blood pressure; providing
Setting participation
The percentage of eligible cardiac rehaindividualized nutrition and
bilitation centers, physical therapy clinics,
The insurance agency dic- rate (SPR)
fitness assessments, nutrition
wellness/fitness centers, and health clubs
tates what services are offered,
classes, fitness plan, one-onin the state that participated in the weight
but not how the services are
one personal training, and folmanagement program
implemented. The use of rellow-up nutrition and fitness
evant weight management Component implemen- The percentage of program protocols
assessments; tracking particiimplemented at each site
guidelines of the American tation rate (CIR)
pant attendance; and reviewThe percentage of program sites that
College of Sports Medicine Setting continuation
ing home exercise and food
have elected to continue conducting the
(ACSM) (15) and the American rate (SCR)
logs or journals. Responses
program for more than 1 year
Dietetic Association (16) is sugwere recoded to dichotomous
gested. For example, the exervariables (yes/no) and the sum
cise physiologist may choose from fitness testing methods
of yes responses tallied to represent the number of prorecommended by ACSM (eg, 6-minute walk test, 1-mile
gram components implemented.
walk test) and the registered dietitian may use his or her
discretion in diet composition or outcome goals.
Statistical analyses of RE-AIM indices

Phase II (months 4-12)

Box. RE-AIM Components and Operational Definitions

Data sources
We used archival participant data and site administrator surveys to evaluate the weight management program.
The insurance agency granted us access to an online
password-protected database containing demographic and
physical measurement data of all program participants.
The university’s institutional review board approved the
study for the protection of human participants. We downloaded, verified, de-identified, and imported archival data
of all participants into SPSS version 14.0 (SPSS, Inc,
Chicago, Illinois).
To gather site-level program evaluation data, we recruited site administrators by mail, e-mail, and telephone (17)

Presenting results using the RE-AIM model first
requires creating operational definitions for multiple components in each of the 5 RE-AIM dimensions (10) (Box).
These components were used to calculate RE-AIM indices
(Appendix). Index calculations used standardized effect
size (18) values from various statistical procedures to
measure multiple components or outcomes in each index.
We used χ2 analysis to compare categorical variables
and repeated measures analysis of variance (ANOVA) to
assess the magnitude of outcome changes over time. In
the indices, “positive” effects were reduced by differential
or “negative” effects (eg, program attrition). This index
calculation method has resulted in negative values in
prior studies (13) for 2 reasons. First, in calculating index
values, differential effects have been subtracted directly
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from outcome effects, overstating the “negative” program
effect. To limit this potential distortion, we calculated a
“proportion of positive effect not explained by differential
effects” by first subtracting the differential (“negative”)
effect size from 1 and then multiplying the difference by
the “positive” effect (Appendix). Second, a negative index
value may still result if the effect size is more than 1.
We resolved this challenge by using effect size measures
whose upper limit was 1.
Effect size measures (and interpretation) included the
squared Cramer phi (φc2) for χ2 tests (small [φc2 ≈ .01],
moderate [φc2 ≈ .09], or large [φc2 > .25]) and the squared
curvilinear correlation coefficient (partial eta squared; η2)
for ANOVA (small [η2 ≈ .01], moderate [η2 ≈ .06], or large
[η2 > .14]) (18,19). All raw index scores ranging from 0 to
1 were multiplied by 100 for summary index values of 0
to 100. Missing data were excluded from analyses, which
were conducted by using SPSS version 14.0.

Results
The data for 1,952 participants from 31 sites were exported, and administrators from 27 of 31 active sites (87.1%
response rate) completed online surveys. Responses from 4
new sites whose participants had not yet completed phase
I of the program were excluded from analysis, resulting
in 23 completed site administrator surveys. The distribution of most of the participants’ measurement data was
skewed, and data are presented as median (interquartile
range) unless otherwise noted.

Individual-level impact ([reach * effectiveness] / 100)
A total of 60,041 adult members were covered by the
insurance agency (N. Henderson, health promotions director, written communication, January 2008). By using the
state obesity (31%) and overweight (36%) prevalence rates
(20), and national prevalence of overweight adults with at
least 1 comorbid condition (66%) (21), we estimated that
32,878 insurance members may have been eligible for
the program. At the time of data collection, 1,952 members had participated (5.9% individual participation rate)
(Table 1).
Baseline physical measurements for men and women
are presented in Table 2. A significantly larger percentage
of participants than the eligible population were women

(80.0% vs 54.1%; P < .001, φc2 = .073), and more of them
were aged 45-54.9 years and fewer of them were aged 65
years or older (P < .001, φc2 = .113), yielding a reach value
(R) of 5.4 (Table 1).
Phase I outcome changes are presented in Table 3. Of
1,647 participants who could have completed phase I (those
who had started the program at least 12 weeks before data
collection), 76.5% had done so. Fewer women (74.8%) than
men (83.7%) completed phase I (P = .001, φc2 = .007), and
completion rates tended to rise with age. Participants who
completed phase I had significant weight loss (13 lb [6.521.4 lb]; P < .001, η2 = .592), and men lost significantly
more weight than women (P < .001, η2 = .050). Differences
in weight loss were also revealed among age groups (P =
.003, η2= .014). These components produced an effectiveness value (E) of 43.8 and an individual-level impact ([R *
E] / 100) of 2.4 (Table 1).

Setting-level impact ([adoption * implementation] / 100)
There were 31 active weight management program sites
out of a total of 352 potential sites in West Virginia at the
time of data collection, resulting in an adoption value (A)
of 8.8 (Table 1). Site survey responses (N = 23) showed
that sites implemented a mean of 12.8 (standard deviation [SD] 1.0) of 14 program components during phase I.
All sites measured weight, waist circumference, body fat
percentage, and blood pressure; tracked attendance; and
provided initial and follow-up nutrition assessments with
a registered dietitian, nutrition classes designed by the
registered dietitian, and an individualized exercise prescription. The least frequently implemented component,
by 15 sites (65%), was having participants maintain home
exercise logs. Implementation survey data yielded an
implementation value (I) of 91.4 and a setting-level impact
([A * I] / 100) of 8.0 (Table 1).

Long-term maintenance ([individual maintenance *
setting maintenance] / 100)
Phase II outcome changes are presented in Table 4. Of
762 participants who could have completed phase II (those
who had started the program at least 1 year before data
collection), 348 (45.7%) had done so (ICRPhII = .457) (Table
1). Excluding the small samples of participants aged 1824.9 years (n = 2) and 65 years or older (n = 9), completion
rates tended to increase with age and be higher in men
in each age group. Participants who completed phase II
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achieved significant weight loss from baseline (15 lb [6.130.3 lb]; P < .001, η2 = .467), shedding 6.7% (2.7%-12.7%)
of baseline body weight. Weight loss was similar among
phase II completers of different age groups (P = .61, η2 =
.011) and between sexes (P = .21, η2 = .005). These values
combined to yield an individual maintenance value (MI) of
21.2 (Table 1).
Four of 18 sites (22%) that had been approved to accept
participants at least 1 year before this study had stopped
or had been disallowed to continue accepting participants,
resulting in a setting maintenance value (MS) of 77.8 and
a long-term maintenance value ([MI * MS] / 100) of 16.5
(Table 1).

Discussion
We achieved our primary objective of using RE-AIM
to evaluate a weight management program. We found
moderate program effectiveness and high implementation, suggesting the program has been beneficial for
participants and can be implemented in a variety of
settings. We found low program reach and adoption, suggesting the program could be improved by recruiting new
participants and sites. Recruitment may prove difficult,
however, because participants must be highly motivated
to enroll in the program, and sites are required to offer
services by highly trained personnel often unavailable
in rural areas of West Virginia. In the long term, site
maintenance was high, but individual maintenance was
fairly low, indicating the program is sustainable but the
services of phase II may need to be revised to improve
participant outcomes. The summary results suggest
this weight management program has potential to be
expanded for more translation and public health benefit
and should be considered a viable model for other public
and private insurers.
Individual short-term and long-term outcome changes
are comparable with those of other behavioral programs
and clinical trials. Short-term attrition from this weight
management program (23.5%) was slightly higher than is
commonly seen in behavioral programs of similar length
(10%-15%), though the median weekly weight loss in this
program is comparable (1.23 lb vs 1.1 lb) (22). This program also compares favorably with clinical trials of similar length, which average 85%-95% completion rates and
approximately 1 lb of weekly weight loss (1,5).

Long-term individual results also compare favorably with other behavioral programs and clinical trials.
Participants who completed phase II (n = 348) lost a mean
of 20.9 (SD, 22.3) lb from baseline, with some recidivism.
Slightly more than half of phase II completers (51.5%)
maintained phase I weight loss or continued losing weight
in phase II. In comparison, approximately 60% to 70% of
weight loss is maintained for a year after treatment in
other short-term behavioral interventions (22). One-year
results indicate more average weight losses but lower
completion rates than randomized control trials of similar
length (1,5).
We also achieved the secondary objective of critiquing
the RE-AIM model and revised index calculations. The
strength of the RE-AIM model is its ability to quantify for
decision makers a program’s strengths and weaknesses.
Comparison with other health promotion program evaluations that used RE-AIM is limited at this point in the
model’s refinement because no 2 studies have used the
same index calculation methods. We believe this study
advances the RE-AIM model by 1) providing methods for
assessing long-term maintenance at the individual and
site levels and 2) addressing 2 methodologic concerns with
existing index calculation methods (ie, negative index values and effect sizes with varying maximum values). The
revised methods in this study produced positive R and MI
values, whereas previously used methods (10) would have
yielded negative values.

Limitations
The study is limited in a number of ways. Multiple
sources of measurement error may have affected the
data, including 1) lack of standardized procedures and
instruments for measuring health outcomes, 2) missing
outcome data, and 3) social desirability of sites when
entering participant data and completing survey items.
Potential error was addressed in multiple ways. Trained
exercise professionals took measurements using accepted
professional standards of practice, the insurance agency
periodically audited site data, we contacted sites to collect
missing data, and all survey recruiting material stressed
the informative (not punitive) nature of the study and
independence of the investigators from the insurance
agency. Measurement error would be more important in
a small clinical trial assessing an intervention’s efficacy
than in this study with its large sample and focus on standardized effect sizes.
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Conclusions
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Tables
Table 1. RE-AIM Model Component and Index Values Used to Evaluate a Weight Management Program, West Virginia, 2004
Component

Valuea

RE-AIM Index

Individual participation rate (IPR)

IPR = 1,952 / 60,041 * (.31 + [.36 * .66])
IPR = .059

Demographic representativeness (DR)

DR = (.073 + .113) / 2
DR = .093
Reach (R)

R = (.059 * [1 – .093]) * 100
R = 5.4

Phase I individual completion rate (ICRPhI)

ICRPhI = 1,260 / 1,647
ICRPhI = .765

Phase I outcome (OPhI)

OPhI = .592

Phase I differential impact (DIPhI)

DIPhI = (.050 + .014) / 2
DIPhI = .032
Effectiveness (E)

E = (.765 * .592 * [1 - .032]) * 100
E = 43.8

Setting participation rate (SPR)

SPR = 31 / 352
SPR = .088
Adoption (A)

Component implementation rate (CIR)

A = (.088 * 100) = 8.8
CIR = 12.8 / 14
CIR = .914

Implementation (I)

I = (.914 * 100) = 91.4

Phase II individual completion rate (ICRPhII)

ICRPhII = 348 / 762
ICRPhII = .457

Phase II outcome (OPhII)

OPhII = .467

Phase II differential impact (DIPhII)

DIPhII = (.005 + .011) / 2
DIPhII = .008
Individual maintenance (MI)

MI = (.457 * .467 * [1 - .008]) * 100
MI = 21.2

Setting continuation rate (SCR)

SCR = 14 / 18
SCR = .778
Setting maintenance (MS)

MS = (.778 * 100) = 77.8

Abbreviation: RE-AIM, reach, effectiveness, adoption, implementation, maintenance.
a Methods of calculating the values are described in the Appendix.
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Table 2. Baseline Measurements of Participants, Weight Management Program, West Virginia, 2004
Women (n = 1,561)
No.a

Measurement

Men (n = 391)

Median

(IQR)b

No.a

Median (IQR)b

Age, y

1,555

49.7 (41.7 to 55.8)

391

51.5 (43.0 to 57.8)

Height, in

1,557

64.0 (63.0 to 66.0)

390

71.0 (69.0 to 73.0)

Weight, lb

1,428

220.8 (192.0 to 258.4)

354

269.9 (232.7 to 333.8)

1,426

38.5 (32.8 to 43.1)

353

37.6 (32.8 to 44.8)

1,359

126.0 (118.0 to 136.0)

330

130.0 (120.0 to 140.0)

Diastolic blood pressure, mm Hg

1,359

(9.9)c

330

82.1 (9.8)c

Body fat, %

1,193

45.9 (41.9 to 49.4)

302

36.1 (31.6 to 42.8)

873

43.0 (38.6 to 47.5)

226

47.4 (43.5 to 53.0)

BMI,

kg/m2

Systolic blood pressure, mm Hg

Waist, in

80.5

Abbreviations: IQR, interquartile range; BMI, body mass index.
a Sample sizes vary because of missing data for some measurements.
b Median and IQR are presented for data with skewed distributions unless otherwise noted.
c Measurement has a normal distribution and is presented as mean (standard deviation).

Table 3. 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management Program, West
Virginia, 2004a
Phase I Completers
(n = 1,260, 76.5%)
End Phase I
No.b

Measurement

Median

Change From Baseline
(IQR)c

No.b

Median (IQR)c

Women (n = 993; 74.8% completion rate)
Weight, lb

971

205.4 (179.0 to 242.5)

970

−12.0 (−19.8 to −6.0)

Weight, %

NA

NA

970

−5.5 (−8.7 to −2.8)

BMI, kg/m2

971

34.6 (30.9 to 40.0)

970

−2.1 (−3.3 to −1.0)

Systolic blood pressure, mm Hg

769

122.0 (113.0 to 130.0)

764

−5.0 (16.1)d

Diastolic blood pressure, mm Hg

769

(8.9)d

764

−3.4 (10.5)d

Body fat, %

804

43.5 (39.7 to 47.9)

740

−2.0 (3.2)d

Waist, in

690

39.9 (36.0 to 44.0)

514

−2.5 (−4.1 to −1.5)

77.1

Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index.
a 1,647 participants could have completed phase I.
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12
weeks).
c Median and IQR are presented for data with skewed distributions unless otherwise noted.
d Measurement has a normal distribution and is presented as mean (standard deviation).
(Continued on next page)
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Table 3. (continued) 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management
Program, West Virginia, 2004a
Phase I Completers
(n = 1,260, 76.5%)
End Phase I
Measurement

No.b

Median

Change From Baseline
(IQR)c

No.b

Median (IQR)c

Men (n = 267; 83.7% completion rate)
Weight, lb

263

251.5 (219.5 to 305.5)

263

−16.9 (−29.3 to −8.0)

Weight, %

NA

NA

263

−6.1 (−10.2 to −3.0)

263

35.1 (30.8 to 41.3)

262

−2.3 (−3.9 to −1.1)

Systolic blood pressure, mm Hg

223

124.0 (117.0 to 132.0)

213

−7.3 (13.6)d

Diastolic blood pressure, mm Hg

223

76.9 (8.7)d

213

−4.6 (9.7)d

Body fat, %

214

33.0 (29.1 to 39.0)

199

−3.6 (4.9)d

Waist, in

199

45.0 (41.0 to 50.8)

148

−2.5 (−4.4 to −1.3)

BMI,

kg/m2

Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index.
a 1,647 participants could have completed phase I.
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12
weeks).
c Median and IQR are presented for data with skewed distributions unless otherwise noted.
d Measurement has a normal distribution and is presented as mean (standard deviation).

Table 4. One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management Program, West
Virginia, 2004a
Phase II Completers
(n = 348, 45.7%)
End Phase II
Measurements

nb

Median

Change From Baseline
(IQR)c

nb

Median (IQR)c

Women (n = 257; 39.5% completion rate)
Weight, lb

251

196.0 (173.4 to 227.4)

251

−15.3 (−28.6 to −6.3)

Weight, %

NA

NA

251

−7.1 (−12.5 to −3.1)

BMI, kg/m2

251

32.7 (29.5 to 38.2)

251

−2.6 (−4.8 to −1.1)

Systolic blood pressure, mm Hg

199

123.8 (12.7)d

197

−5.3 (17.0)d

Diastolic blood pressure, mm Hg

199

75.7

(8.8)d

197

−6.3 (11.2)d

Body fat, %

216

42.5 (6.0)d

188

−2.7 (4.5)d

Waist, in

193

38.0 (35.4 to 41.9)

113

−4.0 (−6.4 to 2.0)

Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index.
a 762 participants could have completed phase II.
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year).
c Median and IQR are presented for data with skewed distributions unless otherwise noted.
d Measurement has a normal distribution and is presented as mean (standard deviation).
(Continued on next page)
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Table 4. (continued) One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management
Program, West Virginia, 2004a
Phase II Completers
(n = 348, 45.7%)
End Phase II
nb

Measurements

Median

Change From Baseline
(IQR)c

nb

Median (IQR)c

Men (n = 91; 51.4% completion rate)
Weight, lb

85

248.5 (217.5 to 289.2)

85

−14.8 (−36.3 to −5.2)

Weight, %

NA

NA

85

−5.4 (−12.9 to −1.8)

85

34.6 (30.1 to 39.8)

85

−2.1 (−5.1 to −0.7)

Systolic blood pressure, mm Hg

67

(14.1)d

65

−7.1 (14.7)d

Diastolic blood pressure, mm Hg

67

76.6 (10.8)d

65

−6.4 (10.4)d

Body fat, %

64

33.2 (6.8)d

56

−2.9 (6.6)d

Waist, in

60

43.3 (38.8 to 50.0)

37

−3.0 (−5.1 to −1.6)

BMI,

kg/m2

125.7

Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index.
a 762 participants could have completed phase II.
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year).
c Median and IQR are presented for data with skewed distributions unless otherwise noted.
d Measurement has a normal distribution and is presented as mean (standard deviation).

Appendix. RE-AIM Components, Indices, and Calculation Equations
Component

RE-AIM Index

Calculation Equation

Individual participation rate (IPR)

No. of participants / no. of adult insurance agency members * (state’s adult obesity prevalence rate + [state’s adult overweight prevalence rate * overweight with at least 1 comorbid condition national prevalence rate])

Demographic representativeness
(DR)

Mean ES (φc2) of sex- and age-bracket χ2 comparisons of program participants and state
residents
Reach (R)

R = (IPR * [1 – DR]) * 100

Phase I individual completion rate
(ICRPhI)

No. of phase I completers / no. participants who could have completed phase I

Phase I outcome (OPhI)

ES (η2) from 1-way RM ANOVA (IV: time; DV: weight among phase I completers)

Phase I differential impact (DIPhI)

Mean ES (η2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among
phase I completers, and 2) IVs: time x sex; DV: weight among phase I completers
Effectiveness (E)

Setting participation rate (SPR)

E = (ICRPhI * OPhI * [1 – DIPhI]) * 100
No. of active sites / (no. of cardiac rehabilitation centers + no. of physical therapy clinics +
no. of hospitals + no. of wellness/fitness centers + no. of health clubs in the state)

Abbreviations: ES, effect size; φc2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable;
DV, dependent variable.
(Continued on next page)
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Appendix. (continued) RE-AIM Components, Indices, and Calculation Equations
Component

RE-AIM Index
Adoption (A)

Component implementation rate
(CIR)

Calculation Equation
A = SPR * 100
Mean no. of “yes” responses to “Program Components” section of site survey / 14

Implementation (I)

I = CIR * 100

Phase II individual completion rate
(ICRPhII)

No. of phase II completers / no. of participants who could have completed phase II

Phase II outcome (OPhII)

ES (η2) from 1-way RM ANOVA (IV: time; DV: weight among phase II completers)

Phase II differential impact (DIPhII)

Mean ES (η2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among
phase II completers, and 2) IVs: time x sex; DV: weight among phase II completers
Maintenance: individual (MI)

Setting continuation rate (SCR)

MI = (ICRPhII * OPhII * [1 – DIPhII]) * 100
No. of active sites that have continued to offer the program for 1 year or longer / no. of
sites that started offering the program 1 year or more before study

Maintenance: setting
(MS)

MS = SCR * 100

Abbreviations: ES, effect size; φc2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable;
DV, dependent variable.
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